Clinical Trial

Postoperative Analgesic Efficacy of Recto Intercostal Nerve Block

Completed
View on ClinicalTrials.gov →
Summary
Laparoscopic cholecystectomy is a frequently performed surgery and the gold standard for the treatment of symptomatic gallstone disease. Although laparoscopic cholecystectomy is considered minimally invasive, it can cause moderate to severe pain in the postoperative period. Poorly controlled early postoperative pain impairs recovery quality and increases the risk of postoperative pulmonary complications, serving as a risk factor for chronic pain development. Multimodal analgesia, including opioids, is used to manage pain following laparoscopic cholecystectomy. However, opioid treatment may lead to side effects such as postoperative nausea and vomiting (PONV), respiratory depression, and constipation. The primary aim of this study is to evaluate the effect of recto-intercostal nerve block as part of multimodal analgesia on intraoperative opioid consumption and postoperative pain scores in patients undergoing laparoscopic cholecystectomy.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-06-03.
Status change: Not Yet Recruiting → Completed 2026-05-13
Trial Details
NCT Number NCT07003698
Lead Sponsor Ankara Etlik City Hospital
Conditions Laparoskopic Cholecystectomy, Recto Intercostal Nerve Block
Enrollment 60 participants
Start Date 2025-06-22
Primary Completion 2026-04-16 (estimated)
Study Completion 2026-04-28 (estimated)
Updated on ClinicalTrials.gov 2026-05-15